The Helios Alliance Applauds Dr. Rahul Gupta’s Appointment to Knoa Foundation Board of Trustees

In this episode of Global Economic Press, Alex Brady discusses the significant appointment of Dr. Rahul Gupta to the Board of Trustees of the Knoa Foundation, a move that plays a crucial role in the transformation of Purdue Pharma into Knoa Pharma. This development is part of a broader effort to hold the pharmaceutical industry accountable for its role in the opioid crisis. The Helios Alliance, a leader in data-driven opioid abatement strategies, has expressed strong support for Dr. Gupta's appointment, highlighting his extensive experience and leadership in addressing the opioid epidemic. The episode delves into the implications of this appointment and the future of opioid abatement strategies, emphasizing the importance of accountability and transparency in deploying opioid settlement resources. The Helios Alliance has been actively involved in developing frameworks for the responsible deployment of opioid settlement funds, particularly in Alabama. Through initiatives like Project Persevere and Project RenewAL, the Alliance has demonstrated a community-centered, data-driven approach to opioid response, which is now being scaled statewide. The transformation of Purdue Pharma into Knoa Pharma, under a $7.4 billion settlement, marks a historic shift in the pharmaceutical industry's accountability. The settlement prohibits Knoa from marketing opioids and requires independent monitoring to ensure safe and responsible delivery of medicines. For more information about The Helios Alliance and their initiatives, visit their website at The Helios Alliance.